Cargando…
Nanotherapeutics in the EU: an overview on current state and future directions
The application of nanotechnology in areas of drug delivery and therapy (ie, nanotherapeutics) is envisioned to have a great impact on public health. The ability of nanotherapeutics to provide targeted drug delivery, improve drug solubility, extend drug half-life, improve a drug’s therapeutic index,...
Autores principales: | Hafner, Anita, Lovrić, Jasmina, Lakoš, Gorana Perina, Pepić, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933707/ https://www.ncbi.nlm.nih.gov/pubmed/24600222 http://dx.doi.org/10.2147/IJN.S55359 |
Ejemplares similares
-
Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020) -
Anti-HIV-1 nanotherapeutics: promises and challenges for the future
por: Mahajan, Supriya D, et al.
Publicado: (2012) -
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
por: Zou, Lili, et al.
Publicado: (2016) -
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
por: Abdalla, Ahmed M.E., et al.
Publicado: (2018) -
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
por: Feng, Jie, et al.
Publicado: (2019)